Robert Cantone

Robert Cantone

Proskauer Rose LLP

Contact
View Bio
RSS

Latest Posts › Expedited FDA Approval

Share:

BridgeBio Transaction Reflects Healthy Market for FDA Priority Review Vouchers

BridgeBio’s recently announced sale of an FDA Priority Review Voucher for $110 million reflects a robust secondary market for these regulatory fast passes. Prices for Priority Review Voucher (“PRVs”) reflect the high stakes...more

5/17/2022  /  Biologics , Expedited FDA Approval , Food & Drug Regulations , Food and Drug Administration (FDA) , Healthcare , License Applications , Life Sciences , Pharmaceutical Industry , Priority Review Vouchers
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide